07:00 , May 10, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Musculoskeletal disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Musculoskeletal disease Tissue injury; muscular dystrophy MicroRNA-206 (miR-206) Mouse studies suggest agonizing miR-206 could be useful for...
08:00 , Jan 7, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Amyotrophic lateral sclerosis (ALS) MicroRNA-206 (miR-206) Studies in mice suggest that increasing miR-206 expression could help delay...
08:00 , Jan 7, 2010 |  BC Innovations  |  Targets & Mechanisms

Targeting miRNAs in ALS

A team from The University of Texas Southwestern Medical Center at Dallas has identified a muscle-specific microRNA-miR-206-that plays a role in the progression of amyotrophic lateral sclerosis.1 The results suggest that muscle cells could be...
07:00 , Jul 30, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer c-Met proto-oncogene (HGFR;...
07:00 , Mar 20, 2008 |  BC Innovations  |  Markers

Micro Management

In the past four years, at least two biotechs have released tests that use mRNA-based gene signatures to predict the likelihood of breast cancer recurrence. Now, research is emerging that suggests microRNAs could also have...
08:00 , Jan 31, 2008 |  BC Innovations  |  Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer ...